CN104546835A
|
|
Application of 3-(benzoyl phenyl) propionic acid derivative in treatment of connexin CX31 mediated skin diseases
|
CN104415019A
|
|
Use of 3-sulfydryl-N-benzyl propanamide compound in restraint of NDM-1
|
CN104415017A
|
|
Application of mercapto-propanol compounds in inhibition of NDM-1
|
CN104367584A
|
|
Application of doxycycline in preparation of antitumor drugs
|
CN103183606A
|
|
4,4'-dibasic benzophenone compound and preparation method thereof
|
CN103183647A
|
|
Novel preparation method of 3-{[2-[3-oxygen-(1,2-benzisothiazole-6-yl)methoxyl-5-(2-hydroxy-4-cyclopentyloxyl)]phenyl}propionic acid
|
CN103172548A
|
|
Preparation method and application of methanesulfonamide compound
|
CN103172617A
|
|
Application of 1,5-2 substituent-1,2,3-triazole trifluoromethyl compound
|
CN103172547A
|
|
Preparation and application of sulfamide derivative
|
CN103159740A
|
|
Preparation and application of 1, 5-distributed-1, 2, 3-triazole trifluoromethyl type compound
|
CN103159650A
|
|
Preparation and application of aromatic heterocyclic sulfonamide compound
|
CN103159691A
|
|
Preparing method and application of isothiocyanate compound
|
CN103172616A
|
|
Novel tyrosine kinase inhibitor 1,4-disubstituted-1,2,3-triazole compound and preparation and applications thereof
|
CN103169700A
|
|
Application of 1,2-benzisothiazole-3-ketone compound in inhibiting caspase-3 activity
|
CN103159739A
|
|
1, 4-disubstituted-1, 2, 3-triazole compounds and preparation method thereof
|
CN103352022A
|
|
Special multi-element trace element additive for biological culture
|
CN103275199A
|
|
Expression and purification of fluorescence recovery protein in blue algae and crystal structure thereof
|
CN103525794A
|
|
Method for separating and purifying inclusion body-type HIV-1 (human immunodeficiency virus-1) protease from prokaryotic system
|
CN102626408A
|
|
Application of isatin thiosemicarbazone compound in inhibition of NDM-1 activity
|
CN103191091A
|
|
Application of sulfonamide compounds in inhibiting NDM-1 activity
|